Wordt geladen...
Add-on perampanel in Lance–Adams syndrome
Perampanel (PER) is the first-in-class selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist that has been licensed and marketed as antiepileptic drug (AED) indicated for patients with partial-onset and primary generalized tonic–clonic seizures. A...
Bewaard in:
| Gepubliceerd in: | Epilepsy Behav Case Rep |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4939387/ https://ncbi.nlm.nih.gov/pubmed/27437182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebcr.2016.05.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|